IP6 GOLD

about Dr. Shamsuddin

“We want what works best: prevention first, treatment that is effective and safe when needed and the ability to choose therapies that compliment each other and produce the best results. This is the kind of medicine that I want for the benefit of all people, and I have dedicated my professional career toward that goal.”

Dr. AbulKalam M. Shamsuddin, MD, PhD is Professor of Pathology at the University of Maryland School of Medicine in Baltimore USA. Since 1975, he has been researching the process of cancer formation, cancer prevention and cancer treatment. In 1985, he started his experiments that led to pioneering the immune enhancing and anti-cancer actions of IP6 and Inositol for which he was awarded the US, European, and Japanese patents. More recently he has demonstrated the IP-6 and Inositol can prevent radiation-induced tissue damage including skin cancer.

Dr. Shamsuddin graduated from Dhaka Medical College in 1972. Following Internship in Massachusetts and Residency training in pathology in Maryland, he was certified by the American Board of Pathology in 1977. In 1980, he received Ph.D. degree from the University of Maryland for his work on colon carcinogenesis. He joined the faculty of the University of Maryland as an Instructor in 1977, and rose through the ranks of Assistant Professor and Associate Professor to become a full Professor in 1988.

Dr. Shamsuddin's research on cancer started at the time he began his doctoral dissertation, in 1975. That work was based on his theory of "field effect phenomenon" and resulted in the subsequent invention of a very simple, accurate and practical mass screening test for cancers of the colorectum and lung with potential utility also for cancers of the breast, prostate, uterine cervix, etc. The colorectal and lung cancer tests are already popular in China. Dr. Shamsuddin's book on this subject, written for health care professionals is entitled Diagnostic Assays for Colon Cancer [CRC Press, Boca Raton, Florida 1991].

Dr. Shamsuddin has been the principal investigator or coinvestigator for many grants from the National Cancer Institute (NCI), the American Cancer Society, and the American Institute of Cancer Research. He is the founding Director and Chairman of the Board of IP-6 Foundation Inc., and Kamolpur Janakallyan Trust, non-profit organizations to support health-care and economic empowerment in impoverished rural Bangladesh.

Natures revolutionary Cancer-fighter & Immune Support Formula

What Doctors Say ....

"……His painstaking research efforts then turned IP6 and its great potential as a chemopreventive and chemotherapeutic agent for cancer. IP6 and inositol compounds now await clinical use for human cancer prevention and therapy………………………"
Kosaku Sakamoto, MD, DMSc
Sakamoto Clinic of Garoenterology

"Dr.Shamsuddin, who as a pathologist at the University of Maryland sees daily the ravages of cancer, made pioneer observations on the effect of IP6 supported by experiments….."
George Webber, MD
Distinguished Professor and Director
Laboratory for Experimental Oncology
Indiana University School of Medicine

"This new cancer-fighter derived from fiber may also prove to be a medicine for the new millennium"
Jose Antonio, Ph.D.

"…..It is certainly in our patient's best interest to give them the opportunity to experience the possibility that IP6 promises. Unlike many of the other natural substances often promoted to cancer patients, I believe that IP6 offers real hope."
Dr. Michael T. Murray N.D.

www.doctormurray.com/Qarchive/ip6.htm